tradingkey.logo
tradingkey.logo
Search

Propanc Biopharma Ord Shs

PPCB
Add to Watchlist
1.941USD
+0.021+1.09%
Close 11-13 16:00(ET)
2.00MMarket Cap
0.00P/E TTM

PPCB Financials

See Propanc Biopharma Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
2.00M
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
570.45
Revenue
0.00
Net Profit
-58.92M
ROE
-138.20%
ROA
-99.62%
Propanc Biopharma Ord Shs Earnings Date
Latest Release
May 14, 2026
EPS / Forecast
-0.28/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Financial Indicators
EPS
-24.60%-12.22
79.76%-1.77
97.73%-7.09
99.96%-0.30
98.91%-9.81
99.60%-8.77
97.71%-312.46
97.93%-805.77
66.59%-900.00
---2.19K
---13.65K
---38.98K
---2.69K
Revenue
----
--0.00
--0.00
----
--0.00
----
----
----
----
----
----
----
----
Net Profit
-77.52%-8.59M
---4.57M
---6.36M
---4.02M
---4.84M
----
----
----
----
----
----
----
----
Debt to assets ratio
0.40%3.53%
-57.55%3.61%
-34.34%3.63%
-99.74%3.92%
-99.79%3.52%
-99.34%8.49%
-99.77%5.53%
275.05%1530.23%
367.92%1711.28%
--1283.64%
--2431.89%
--408.00%
--365.72%
Revenue
----
--0.00
--0.00
----
--0.00
----
----
----
----
----
----
----
----
Operating profit
-83.43%-8.57M
---3.46M
---6.40M
---3.65M
---4.67M
----
----
----
----
----
----
----
----
Net Profit
-77.52%-8.59M
---4.57M
---6.36M
---4.02M
---4.84M
----
----
----
----
----
----
----
----
Current assets
-8.73%8.00M
--8.54M
--8.22M
--7.71M
--8.76M
----
----
----
----
----
----
----
----
Total current liabilities
-9.30%3.24M
--3.35M
--3.48M
--3.62M
--3.57M
----
----
----
----
----
----
----
----
Total assets
-42.55%10.33M
--12.78M
--14.33M
--15.11M
--17.98M
----
----
----
----
----
----
----
----
Total liabilities
-9.89%3.26M
--3.38M
--3.51M
--3.66M
--3.61M
----
----
----
----
----
----
----
----
Total equity
-50.77%7.07M
--9.40M
--10.83M
--11.45M
--14.36M
----
----
----
----
----
----
----
----
Net operating income
-1.61%-1.97M
---1.60M
---1.14M
---999.14K
---1.94M
----
----
----
----
----
----
----
----
Net investment
100.00%0.00
---21.00
---154.00
---2.27K
---2.49K
----
----
----
----
----
----
----
----
Net financing
-44.43%1.40M
--1.98M
--981.61K
--965.10K
--2.53M
----
----
----
----
----
----
----
----

FAQs

What are the current assets of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its current assets were 8.54M, with a year-on-year change of 2.27.

What are the total assets of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its total assets of Propanc Biopharma Ord Shs were 12.78M, with a year-on-year change of -34.90.

What are the total liabilities of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its total liabilities of Propanc Biopharma Ord Shs were 3.38M, with a year-on-year change of -41.00.

What is the total equity of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its total equity of Propanc Biopharma Ord Shs was 9.40M, with a year-on-year change of -32.39.

What is the net operating income of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its net operating income of Propanc Biopharma Ord Shs was -18.19M, with a year-on-year change of 68.25.

What is the net financing of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its net financing of Propanc Biopharma Ord Shs was 6.46M, with a year-on-year change of 1215.79.

What is the Earnings Per Share (EPS) of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its Earnings Per Share (EPS) was -17.62, with a year-on-year change of 95.25.

What is the net income of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its net income was -19.79M, with a year-on-year change of 66.41.

What is the debt-to-asset ratio of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its debt-to-asset ratio was 3.61, with a year-on-year change of -57.55.

What is the Return on Equity (ROE) of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its Return on Equity (ROE) was -169.86, with a year-on-year change of 85.40.

What is the Return on Assets (ROA) of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its Return on Assets (ROA) was -116.39, with a year-on-year change of 80.54.

What is the operating profit of Propanc Biopharma Ord Shs?

According to Propanc Biopharma Ord Shs's FY2026 earnings report, its operating profit was -18.19M, with a year-on-year change of 68.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.